Skip to content

Jonathan W. Friedberg

The University of Texas MD Anderson Cancer Center

1 paper in the Anchorcite directory, published in 2017, cited 6,172 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Sattva Swarup Neelapu · 1 paper
  • Frederick Lundry Locke · 1 paper
  • Nancy L. Bartlett · 1 paper
  • Lazaros J. Lekakis · 1 paper
  • David Bernard Miklos · 1 paper
  • Caron Alyce Jacobson · 1 paper
  • Ira Braunschweig · 1 paper
  • Olalekan O. Oluwole · 1 paper

Papers

  1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine · 2017 · 6,172 citations

    BACKGROUND: In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after the failure of conventional therapy. METHODS: anti-CD19 CAR T cells per kilogram…

Metadata from OpenAlex (CC0).